lobbying_activities: 2299117

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2299117	c3a1e7a0-52d6-4d75-be2c-43a2cfa2230b	Q2	BAUSCH HEALTH COMPANIES	401104942	BAUSCH HEALTH COMPANIES	2019	second_quarter	HCR	General issues related to health care and pharmaceuticals; issues related to opioids and opioid withdrawal syndrome; drug pricing; patent reform; eye health issues.	Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE		157500	0	0	2019-07-03T10:39:30.273000-04:00